Published in Am J Sports Med on June 04, 1997
Spondylolysis: a critical review. Br J Sports Med (2000) 1.39
Lower trunk kinematics and muscle activity during different types of tennis serves. Sports Med Arthrosc Rehabil Ther Technol (2009) 0.95
The value of combining single photon emission computerised tomography and computerised tomography in the investigation of spondylolysis. Eur Spine J (2004) 0.90
The value of SPECT in the detection of stress injury to the pars interarticularis in patients with low back pain. J Orthop Surg Res (2010) 0.90
Return to sports activity by athletes after treatment of spondylolysis. World J Orthop (2010) 0.87
Comparing spondylolysis in cricketers and soccer players. Br J Sports Med (2004) 0.85
An 8-stage model for evaluating the tennis serve: implications for performance enhancement and injury prevention. Sports Health (2011) 0.84
Spondylolysis in young tennis players. Br J Sports Med (2006) 0.79
The clinical rehabilitation of spine and spinal cord disorders: detection and evaluation using SPECT/CT. Neural Regen Res (2014) 0.77
Traumatic spondylolysis in a heptathlete: a case history and review. J Chiropr Med (2005) 0.75
Ossicles of lumbar articular facets: normal variant or spondylolytic variant? Skeletal Radiol (2012) 0.75
Evaluation and management of lower back pain in young athletes. Transl Pediatr (2017) 0.75
A gene map of the human genome. Science (1996) 14.32
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet (2009) 3.89
Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab (1981) 3.18
Costs and use of mental health services before and after managed care. Health Aff (Millwood) (1998) 2.77
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci (1999) 2.32
Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem (1997) 1.76
Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A (1986) 1.65
Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett (1986) 1.53
The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol (1988) 1.49
Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci U S A (1991) 1.46
Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP. Cephalalgia (1995) 1.44
An evaluation of coronal microleakage in endodontically treated teeth. Part I. Time periods. J Endod (1987) 1.43
Lissencephaly with cerebellar hypoplasia (LCH): a heterogeneous group of cortical malformations. Neuropediatrics (2001) 1.27
Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry (1987) 1.27
Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab (1987) 1.26
Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry (1997) 1.24
Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol (1981) 1.22
Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol (1999) 1.21
Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab (1993) 1.18
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
Cerebral circulation and norepinephrine: relevance of the blood-brain barrier. Am J Physiol (1976) 1.16
Intracranial haemorrhage induced at arterial pressure in the rat. Part 2: Short term changes in local cerebral blood flow measured by autoradiography. Neurol Res (1984) 1.12
Centralization of the radial club hand: an ulnar surgical approach. J Hand Surg Am (1981) 1.10
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab (1981) 1.07
An evaluation of coronal microleakage in endodontically treated teeth. Part II. Sealer types. J Endod (1987) 1.07
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett (1985) 1.07
Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke (1990) 1.05
Costs of detecting and treating cancer of the uterine cervix in North-East Scotland in 1971. Lancet (1975) 1.05
Migraine and the blood-brain barrier. Lancet (1977) 1.04
The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J Cereb Blood Flow Metab (2000) 1.02
Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide. Am J Physiol (1980) 1.02
Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury. Gene Ther (2007) 1.00
Comparison of the effects of potassium and pH on the calibre of cerebral veins and arteries. Pflugers Arch (1982) 0.99
Effect of the calcium antagonist nimodipine on local cerebral blood flow: relationship to arterial blood pressure. J Cereb Blood Flow Metab (1984) 0.99
Catecholamines and the relationship between cerebral blood flow and glucose use. Am J Physiol (1986) 0.99
Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiol (1976) 0.98
The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis. Psychol Med (1989) 0.98
Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett (1992) 0.98
Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1990) 0.97
Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab (1982) 0.96
Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1986) 0.96
Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand (1984) 0.96
Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab (1988) 0.96
Feline cerebral veins and arteries: comparison of autonomic innervation and vasomotor responses. J Physiol (1982) 0.95
Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab (1988) 0.94
NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. J Cereb Blood Flow Metab (2000) 0.94
Action of dopamine agonists on brain vessels in vitro and after in vivo microapplication. Acta Neurol Scand Suppl (1977) 0.94
Inhibition of nitric oxide synthesis: effects on cerebral blood flow and glucose utilisation in the rat. J Cereb Blood Flow Metab (1993) 0.94
Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ. J Cereb Blood Flow Metab (1991) 0.94
Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences. Surg Neurol (1985) 0.94
Mental health and substance abuse benefits in carve-out plans and the Mental Health Parity Act of 1996. J Health Care Finance (1998) 0.93
On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease. J Neurochem (1992) 0.92
Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cereb Blood Flow Metab (1990) 0.92
Specific expression of the cell cycle regulation proteins, GADD34 and PCNA, in the peri-infarct zone after focal cerebral ischaemia in the rat. Eur J Neurosci (2002) 0.92
Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. Eur J Neurosci (2000) 0.91
Recirculation model following MCA occlusion in rats. Cerebral blood flow, cerebrovascular permeability, and brain edema. J Neurosurg (1985) 0.91
Focal cerebral ischemia in the rat: topography of hemodynamic and histopathological changes. Ann Neurol (1984) 0.91
The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum (1992) 0.91
Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett (1990) 0.91
Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels. Acta Physiol Scand (1978) 0.91
Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J Cereb Blood Flow Metab (1997) 0.91
Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psychiatr Serv (1998) 0.90
Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult. J Cereb Blood Flow Metab (2000) 0.90
Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion. Brain Res (2001) 0.90
Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists. Br J Pharmacol (1985) 0.89
Axonal injury caused by focal cerebral ischemia in the rat. J Neurotrauma (1998) 0.88
Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cereb Blood Flow Metab (1996) 0.88
Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia. Neuroreport (1999) 0.87
Cerebrovascular permeability following MCA occlusion in the rat. The effect of halothane-induced hypotension. J Neurosurg (1982) 0.87
Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion. Brain Res (1997) 0.87
Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J Neurosurg (1991) 0.86
Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia. Ann Neurol (1991) 0.86
The distribution of alterations in energy metabolism in the rat brain produced by apomorphine. Brain Res (1982) 0.86
Distribution and vasomotor effects of peptide HI (PHI) in feline cerebral blood vessels in vitro and in situ. Regul Pept (1985) 0.86
Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol (1985) 0.86
Influence of dopaminergic systems on the lateral habenular nucleus of the rat. Brain Res (1980) 0.86
Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-[(125)I]-iodophenyl)-N'-methylguanidine ([(125)I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation. Nucl Med Biol (2000) 0.86
More evidence for the insurability of managed behavioral health care. Health Aff (Millwood) (1999) 0.86
Therapeutic potential of endothelin receptor antagonists in experimental stroke. J Cardiovasc Pharmacol (1995) 0.85
Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1989) 0.85
Specific alterations in local cerebral glucose utilization following striatal lesions. Brain Res (1982) 0.85
Ischaemic brain damage associated with tissue hypermetabolism in acute subdural haematoma: reduction by a glutamate antagonist. Acta Neurochir Suppl (Wien) (1990) 0.85
The effects of whirlpool and the dependent position on lower extremity volume. J Orthop Sports Phys Ther (1992) 0.85
Cerebrovascular smooth muscle reactivity: a critical appraisal of in vitro and in situ techniques. J Cereb Blood Flow Metab (1984) 0.85
Nerve fibers containing neuropeptide Y in the cerebrovascular bed: immunocytochemistry, radioimmunoassay, and vasomotor effects. J Cereb Blood Flow Metab (1987) 0.85
Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use. Brain Res (1989) 0.84
Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: attenuation of damage after transient ischemia. J Cereb Blood Flow Metab (2000) 0.84
Cerebrovascular responses to capsaicin in vitro and in situ. Br J Pharmacol (1990) 0.84
Correlation of triphenyltetrazolium chloride perfusion staining with conventional neurohistology in the detection of early brain ischaemia. Neuropathol Appl Neurobiol (1989) 0.84
Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Br J Pharmacol (1994) 0.84
The effect of diazepam upon local cerebral glucose use in the conscious rat. Neuroscience (1986) 0.84
The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia. Brain Res (1992) 0.84
Best practices: dissemination of guidelines for the treatment of major depression in a managed behavioral health care network. Psychiatr Serv (2001) 0.83
Endothelin-mediated vascular tone following focal cerebral ischaemia in the cat. J Cereb Blood Flow Metab (1996) 0.83
Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. Proc Natl Acad Sci U S A (1990) 0.83
Proteomic analysis of gliomas. Br J Neurosurg (2007) 0.83
Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice. J Cereb Blood Flow Metab (2000) 0.83
The effect of postmortem delay on the distribution of microtubule-associated proteins tau, MAP2, and MAP5 in the rat. Mol Chem Neuropathol (1997) 0.83